All the latest from Verge

Read our most recent News, Publications, and Blog posts.

News - June 17, 2026

STAT News: “Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials”
Verge’s CEO, Alice Zhang, and Head of Product & Engineering, Emily Ripka, spoke to STAT News about the release of vBx-1.0, the company’s breakthrough foundation model for precision neurology.
Read more

News - June 16, 2026

Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology
By Verge Labs
Read more

Report - June 16, 2026

Introducing vBx-1.0
By Verge Labs
Read more

News - June 9, 2026

Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia’s CNS Pipeline Using Human Data
By Verge Labs
Read more

Blog - May 27, 2026

Why We’re Becoming Verge Labs
By Alice Zhang
Read more

Blog - May 27, 2026

What We Learned From The Trial of Our First AI-Discovered Drug
By Alice Zhang
Read more

Publication - February 1, 2026

Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635
By Gontier G, Kim G + 17 more
Read more

News - April 7, 2025

Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in
By Verge Genomics
Read more

News - November 20, 2024

Lilly selects two ALS targets from CONVERGE® collaboration
By Verge Genomics
Read more

Publication - January 1, 2024

Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
By Martirosyan A, Ansari R + 14 more
Read more

News - November 29, 2023

VRG50635 proof-of-concept study initiated in patients with ALS
By Verge Genomics
Read more

News - October 31, 2023

Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration
By Verge Genomics
Read more

News - September 8, 2023

Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases
By Verge Genomics
Read more

News - June 15, 2023

Positive Phase 1 safety and tolerability data for VRG50635
By Verge Genomics
Read more

Publication - December 1, 2022

Single-nucleus co-expression networks of dopaminergic neurons support iron accumulation as a plausible explanation to their vulnerability in Parkinson’s disease
By Gómez-Pascual A, Martirosyan A + 12 more
Read more

News - November 14, 2022

Alice Zhang named to Fortune 40 Under 40 and Fierce Biotech’s Fiercest Women in Life Sciences
By Verge Genomics
Read more

News - October 31, 2022

First-in-human dosing of VRG50635 begins in Phase 1 trial
By Verge Genomics
Read more

News - October 12, 2022

Alice Zhang honored by Goldman Sachs as one of 2022’s Most Exceptional Entrepreneurs
By Verge Genomics
Read more

News - September 12, 2022

Fierce Biotech names Verge Genomics a 2022 “Fierce 15” biotech company
By Verge Genomics
Read more

Publication - February 1, 2022

Systematic comparative analysis of strand-specific RNA-seq library preparation methods for low input samples
By Naphade S, Bhatnagar R + 3 more
Read more

News - July 8, 2021

Verge Genomics and Eli Lilly announce three-year ALS collaboration
By Verge Genomics
Read more

News - October 5, 2020

New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology
By Verge Genomics
Read more

Publication - June 1, 2020

A framework for integrating directed and undirected annotations to build explanatory models of cis-eQTL data
By Lamparter D, Bhatnagar R + 4 more
Read more

Publication - February 1, 2018

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
By Shi Y, Lin S + 7 more
Read more